Merit Medical (NSDQ:MMSI) has licensed a novel surgical device designed to ensure drain placement in the pleural cavity from Pleuratech, according to a Young America Capital press release posted this week.
The device is Denmark-based Pleuratech’s flagship product, the KatGuide, and is designed to guide chest tubes to the part of the pleural cavity which needs draining to reduce misplaced drains and increase surgical success rates.
The companies did not release the exact terms of the deal, but said that it was a multimillion dollar license agreement, according to a press release.
“As a leading manufacturer and marketer of proprietary disposable medical devices, Merit Medical Systems, Inc. is excited to add the KatGuide to our current portfolio of products. This innovative medical device delivers to clinicians a unique tool proven to improve the efficacy of chest tube placement. The resulting benefits will help ensure conditions for optimal drainage and, therefore, improve patient care,” Merit Medical chair & CEO Fred Lampropoulos said in a press release.
In June, Merit Medical said that its Embosphere device won expanded de novo clearance from the FDA to treat benign prostatic hyperplasia.
The post Merit Medical licenses KatGuide pleural drain tech from Pleuratech appeared first on MassDevice.
from MassDevice http://ift.tt/2xF3h18
Cap comentari:
Publica un comentari a l'entrada